Ruboxistaurin (RBX) May Reduce Risk of Vision Loss in Diabetics

Ruboxistaurin (RBX) May Reduce Risk of Vision Loss in Diabetics

Note: This article will be emailed to your friend.

A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association’s journal Diabetes brings hopeful news to the 18 million people in the United States — and millions more worldwide — with type 1 or type 2 diabetes. Initial results of the Phase III [...]

Read the rest of this article (259 words)

Please fill in the following fields

* - Required

Your Name: *

Your E-Mail: *

Your Remarks:

Friend's Name: *

Friend's E-Mail: *

Protected by Comment Guard Pro